Day 3 of #ASCO25 ! Honored to be presenting on how social determinants of health affect immunotherapy use in Stage III NSCLC patients after definitive chemoradiation @ascocancer.bsky.social @bidmcreseach.bsky.social @bidmc-cancercenter.bsky.social #TuftsMedicalCenter
2
0
0
0